SCHEMBL3360174

SCHEMBL3360174

CN1CCN(CC2CO2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.42
HRH4 Q9H3N8 1/20 0.42
HTR2A P28223 3/20 0.41
HTR2C P28335 2/20 0.41
HRH1 P35367 2/20 0.41
TP53 P04637 1/20 0.39
HBB P68871 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ACHE P22303 1/20 0.35
MC4R P32245 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCD Q05655 1/20 0.33
ADRA1A P35348 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PAOX Q6QHF9 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3359924 0.92 CHKA (0.41) HRH3HRH4HTR2AHTR2CHRH1
SCHEMBL3211746 0.87
SCHEMBL354055 0.87 TP53 (0.48) TP53HBBSMN1; SMN2ADRA1ATDP1
SCHEMBL20257559 0.84 CHRM2 (0.43) HRH3HRH4HTR2AHTR2CHRH1
SCHEMBL4742544 0.82 L3MBTL1 (0.35) HRH3HRH4HTR2AHTR2CHRH1
SCHEMBL10005232 0.81 HTR2A (0.37) HRH3HRH4HTR2AHTR2CHRH1
SCHEMBL16274766 0.80 TP53 (0.42) TP53HBBSMN1; SMN2ADRA1ATDP1
SCHEMBL11256210 0.78 TP53 (0.41) TP53HBBSMN1; SMN2ADRA1ATDP1
SCHEMBL13043950 0.77 HTR2B (0.38) HRH3TP53HBBSMN1; SMN2ADRA1A
SCHEMBL13043936 0.77 HTR2B (0.38) HRH3TP53HBBSMN1; SMN2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736354-A High-water-solubility cationic cyclodextrin derivative and preparation method and application thereof 南京盛德创赢生物科技有限公司 2024-03-22 CN claimed
EP-4056613-B1 BLOCK POLYMER, POLYMER COMPOSITION, AND ADHESIVE ENEOS MAT CORPORATION (JP) 2026-04-22 EP disclosed
US-20250382452-A1 RESIN COMPOSITION, MOLDED BODY, MULTILAYER STRUCTURE, AND METHOD FOR PRODUCING MULTILAYER STRUCTURE KURARAY CO., LTD. (JP) 2025-12-18 US disclosed
US-12359055-B2 Resin composition, method for producing resin composition, and molded article KURARAY CO., LTD. (JP) 2025-07-15 US disclosed
EP-4563653-A1 RESIN COMPOSITION, MOLDED BODY, MULTILAYER STRUCTURE, AND METHOD FOR PRODUCING MULTILAYER STRUCTURE Kuraray Co., Ltd. (JP) 2025-06-04 EP disclosed
CN-113825775-B Resin composition, method for producing resin composition, and molded article 株式会社可乐丽 2025-04-04 CN disclosed
CN-119604577-A Resin composition, molded article, laminated structure, and method for producing laminated structure 株式会社可乐丽 2025-03-11 CN disclosed
US-20250059306-A1 MODIFIED HYDROGENATED BLOCK COPOLYMER AND RESIN COMPOSITION KURARAY CO., LTD. (JP) 2025-02-20 US disclosed
EP-4450526-A1 MODIFIED HYDROGENATED BLOCK COPOLYMER AND RESIN COMPOSITION Kuraray Co., Ltd. (JP) 2024-10-23 EP disclosed
WO-2024162448-A1 GREASE COMPOSITION 株式会社クラレ 2024-08-08 WO disclosed
CN-101724127-A Polymer, rubber composition and tire using the same SUMITOMO RUBBER IND 2010-06-09 CN disclosed
EP-2184318-A2 Rubber composition and tire Sumitomo Rubber Industries, Ltd. (JP) 2010-05-12 EP disclosed
EP-2182028-A1 Rubber composition and tire Sumitomo Rubber Industries, Ltd. (JP) 2010-05-05 EP disclosed
US-20100105826-A1 RUBBER COMPOSITION AND TIRE SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2010-04-29 US disclosed
US-20100099810-A1 POLYMER, RUBBER COMPOSITION AND TIRE USING THE SAME SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2010-04-22 US disclosed
US-20100099795-A1 RUBBER COMPOSITION AND TIRE SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2010-04-22 US disclosed
EP-2177562-A2 Polymer, rubber composition and tire using the same Sumitomo Rubber Industries, Ltd. (JP) 2010-04-21 EP disclosed
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-04-30 US disclosed
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-04-30 US disclosed
US-4497812-A ANTIHISTIMINES;ANTINFLAMMATORY AGENTS;ANTIALLERGENS;DIURETICS;CARDIOVASCULAR THERAPY SOCIETE CORTIAL, S.A. (FR) 1985-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same IMPA1, IMPDH1, IPO5 HRH3 1002/4885HRH4 1027/4885HTR2A 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.